Rapid and sustained cognitive recovery in APP/PS1 transgenic mice by co-administration of EPPS and donepezil

Hye Yun Kim, Hyunjin Vincent Kim, Dongkeun K. Lee, Seung Hoon Yang, Young Soo Kim

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Alzheimer's disease (AD) is a neurodegenerative disease characterized by sequential progression of pathological events, such as aggregation of amyloid-β proteins, followed by outward symptoms of cognitive impairments. Given that a combination of different therapeutic strategies often provides more rapid and effective outcomes in diverse areas of clinical treatment, we hypothesized that administration of anti-amyloid drugs with cognitive enhancers would result in synergistic effects in AD treatment. Here, we co-administered 4-(2-hydroxyethyl)-1-piperazinepropane-sulphonic acid (EPPS), an amyloid-clearing chemical, and donepezil, an acetylcholinesterase inhibitor, to determine whether they could serve complementary roles for each other in regards to AD treatment. We found that oral administration of these two molecules led to a rapid and consistent cognitive improvement in APP/PS1 transgenic mice. Although there was no evidence for synergistic effects, our results indicated that EPPS and donepezil function complementary to each other without altering their individual effects. Thus, the combined use of disease-modifying and symptomatic relief drugs may be a promising approach in the treatment of AD.

Original languageEnglish
Article number34165
JournalScientific reports
Publication statusPublished - 2016 Oct 31

Bibliographical note

Publisher Copyright:
© The Author(s) 2016.

All Science Journal Classification (ASJC) codes

  • General


Dive into the research topics of 'Rapid and sustained cognitive recovery in APP/PS1 transgenic mice by co-administration of EPPS and donepezil'. Together they form a unique fingerprint.

Cite this